Podoconiosis

IMPRESS – Improving access to integrated Morbidity management and disability PREvention Services through Stigma reduction for people with lower limb lymphoedema in Ethiopia: Feasibility and quasi-experimental study (year 2)

  • Formative component: What is the capacity of the integrated morbidity management and disability prevention (MMDP) programme to incorporate a stigma reduction intervention for people with lower limb lymphoedema, and what are the barriers and facilitators to this?
  • Intervention component: Is the stigma reduction intervention effective in increasing demand and access to services within an integrated MMDP programme for people with lower limb lymphoedema?
Countries: Ethiopia

IMPRESS – Improving access to integrated Morbidity management and disability PREvention Services through Stigma reduction for people with lower limb lymphoedema in Ethiopia: Feasibility and quasi-experimental study

Formative: What is the capacity of the integrated morbidity management and disability prevention (MMDP) programme to incorporate a stigma reduction intervention for people with lower limb lymphoedema, and what are the barriers and facilitators to this?

Intervention: Is the stigma reduction intervention effective in increasing demand and access to services within an integrated MMDP programme for people with lower limb lymphoedema?

Countries: Ethiopia

Enhanced self-care protocol for case management of severe lymphoedema

This study aims to determine if the addition of lymphatic stimulating activities to community-based home-care for lymphoedema can improve outcomes for people affecetd by moderate to late stage disease. 

Countries: Bangladesh | Ethiopia

The Global Atlas of Podoconiosis

Through funding from the Wellcome Trust to develop a global atlas of podoconiosis. We aim to advance new knowledge on the geographical distribution and spatial epidemiology of the disease.

i. Conduct national cross-sectional surveys in selected countries to validate the environmental predictive model developed using the mapping data in Ethiopia.

ii. Create evidence consensus maps, develop risk maps and ground-truthing work and delineate the spatial distribution and geographical limits of podoconiosis globally.

iii. Estimate the global burden of podoconiosis by quantifying the number affected, the population at risk and DALYs attributable.

iv. Estimate how much it will cost to control or eliminate podoconiosis globally.

 

Countries: Ethiopia | Cameroon | Rwanda | Uganda | Burundi | India
Diseases: Podoconiosis

Identification of endemic plants with potential for lymphoedema treatment.

Do endemic Ethiopian plant extracts have potential for use in lymphoedema management?

Countries: Ethiopia

Development of a diagnostic device for podoconiosis

Can bioielectrical impedance spectroscopy (BIS) identify patients with podoconiosis lymphoedema?

Countries: Ethiopia
Diseases: Podoconiosis

Integration and scale up of community-based holistic care package for people with lymphoedema in Ethiopia

What are the key elements that constitute optimal physical and psychosocial care for lymphoedema of many causes?

How (and to what extent) does integration of the lymphoedema intervention occur in the different ‘functions’ of the health system? What are the critical factors that influence the process of integration?

Countries:

Pages